Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sec1 family domain-containing protein 1 (SCFD1) is a member of the Sec1/Munc18 (SM) family of proteins, widely conserved across species[2][3]. SCFD1 is involved in the regulation of membrane fusion events by cooperating with SNARE complexes, playing a crucial role in vesicular transport between the endoplasmic reticulum (ER) and the Golgi apparatus[2][3]. This protein is essential for proper protein transport, Golgi-to-ER retrograde trafficking, and the assembly of SNARE complexes, acting via interactions such as with COG4 and potentially syntaxin[3][5]. Functional studies (particularly in model organisms) show that loss-of-function mutations in SCFD1 can cause severe developmental abnormalities, including dilated cardiomyopathy, craniofacial defects, and defects in protein homeostasis due to disrupted trafficking and resultant ER stress[2]. Although it is not generally considered a classic therapeutic target (e.g., receptor or enzyme), its importance in fundamental cellular processes—and its association with human diseases such as cardiomyopathy and rare genetic syndromes—makes it a significant protein for basic and translational research[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sec1 family domain-containing protein 1 (SCFD1).